FDA First-Cycle Approval Rate For NMEs Leaps To 50% In 2003
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA’s efforts to increase first-cycle approvals appear to be paying off, with the agency showing a significant improvement in 2003 compared to 2002.